QUEST INGREDIENTS - Flavours and botanical extracts producer sold to US investor backed group
QUEST INGREDIENTS
Flavours and botanical extracts
producer sold to US investor backed group
Flavours and botanical extracts producer sold to US investor
backed group
Alinea has advised Quest Nutra Pharma, the ultimate shareholder of Quest Ingredients on their sale to FDL, a portfolio company of Highlander Partners.
The sale of Quest Ingredients is a great example of how Alinea goes beyond the expectations of clients, delivering an international company sale, from family ownership, within a short space of time.
You call yourself a “corporate finance” firm, but Alinea has been much more than that to us on this project.
We have greatly appreciated your professional approach to the process, personal attention, words of wisdom, attention to detail, tenacious negotiation, non-stop availability & communication and the overall support.
Mohamed Hassam, Group Managing Director, Quest Nutra Pharma
Quest Ingredients, headquartered in Hereford, England, is a manufacturer of high-quality proprietary food flavours, animal feed flavours and active botanical extracts with a repeat client base across the food and beverage, pharmaceutical and agricultural sectors.
Operations will continue to be conducted from Quest Ingredients’ existing facility in Hereford, and its employees will join the FDL team. The transaction supports FDL’s stated strategic objective of expanding in its core markets and customer base in Europe and the United States where there continue to be abundant opportunities for growth.
Eric Beatty, CEO of FDL, said, “We believe the addition of Quest Ingredients is strategic and highly complementary to FDL’s existing portfolio of ingredients and formulated solutions. We are excited to offer Quest Ingredients’ unique process capabilities to existing FDL customers and expand services to Quest Ingredients’ customers with FDL’s products and innovation capabilities. We are excited to work with the Quest Ingredients team to continue growing the combined business.”
Chaz Thomas, a Director of Highlander and a board member of FDL, stated, “This acquisition strengthens FDL’s ability to deliver customized flavour and botanical extracts across both customer bases by expanding our capabilities and innovations expertise.
Jeff L. Hull, President and CEO of Highlander and FDL board member, added, “This acquisition reconfirms our strategy of executing on attractive add-on acquisitions that enhance and expand FDL’s existing applications expertise and product offerings.
FDL, founded in 1884 and headquartered in London, UK, is a formulator, developer and manufacturer of proprietary taste and nutrition ingredient solutions serving food, beverage, confections and other consumer markets. FDL serves a global customer base with operations in Europe, US and Asia.
Highlander Partners is a Dallas-based private investment firm with more than $2 billion of its own proprietary capital. The firm focuses on making investments in businesses in targeted industries in which the principals of the firm have significant operating and investing experience.
Alongside Alinea, Higgs LLP provided legal advice to Quest Nutra Pharma and Malcolm Cook provided financial advice as Non-Executive Director of Quest Nutra Pharma.